Romain Aucagne

611 total citations
18 papers, 291 citations indexed

About

Romain Aucagne is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Romain Aucagne has authored 18 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Oncology. Recurrent topics in Romain Aucagne's work include Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related gene regulation (3 papers). Romain Aucagne is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer-related gene regulation (3 papers). Romain Aucagne collaborates with scholars based in France, Canada and Luxembourg. Romain Aucagne's co-authors include Laurent Delva, Jean Bastié, Anne Largeot, Éric Solary, Brice Lagrange, Jérôme Paggetti, Nathalie Droin, Arlette Hammann, Laurent Martin and Régine Losson and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Research.

In The Last Decade

Romain Aucagne

17 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Romain Aucagne France 9 205 64 58 43 34 18 291
Natallia Mikhalkevich United States 6 166 0.8× 94 1.5× 66 1.1× 38 0.9× 39 1.1× 8 283
Antonella Santoro United Kingdom 6 195 1.0× 116 1.8× 71 1.2× 38 0.9× 26 0.8× 10 290
Aissa Benyoucef Canada 11 337 1.6× 78 1.2× 63 1.1× 76 1.8× 38 1.1× 14 408
Bhumi Patel United States 7 150 0.7× 105 1.6× 80 1.4× 23 0.5× 78 2.3× 9 378
Jéssica González Spain 10 245 1.2× 44 0.7× 89 1.5× 56 1.3× 55 1.6× 25 368
Alix Rousseau France 5 199 1.0× 75 1.2× 40 0.7× 30 0.7× 54 1.6× 6 281
I‐Jun Lau United Kingdom 6 276 1.3× 132 2.1× 32 0.6× 36 0.8× 79 2.3× 7 354
Natalina Elliott United States 8 140 0.7× 81 1.3× 93 1.6× 22 0.5× 93 2.7× 17 290
Ashley Pandolfi United States 5 141 0.7× 99 1.5× 138 2.4× 32 0.7× 86 2.5× 6 312

Countries citing papers authored by Romain Aucagne

Since Specialization
Citations

This map shows the geographic impact of Romain Aucagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romain Aucagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romain Aucagne more than expected).

Fields of papers citing papers by Romain Aucagne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romain Aucagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romain Aucagne. The network helps show where Romain Aucagne may publish in the future.

Co-authorship network of co-authors of Romain Aucagne

This figure shows the co-authorship network connecting the top 25 collaborators of Romain Aucagne. A scholar is included among the top collaborators of Romain Aucagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romain Aucagne. Romain Aucagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Galland, Loïck, Valentin Dérangère, David Rageot, et al.. (2025). Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet. Journal of Clinical Investigation. 135(13). 3 indexed citations
2.
Guidez, Fabien, Cyril Fournier, Anne Largeot, et al.. (2024). Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia. Communications Biology. 7(1). 753–753. 1 indexed citations
3.
Aucagne, Romain, et al.. (2024). Abstract 3864: Role of NK/TAM cross-talk on T-CD8+ recruitment and efficacy of chemoimmunotherapy and MEKi combination in "cold" tumors. Cancer Research. 84(6_Supplement). 3864–3864. 1 indexed citations
4.
Maqbool, Muhammad Ahmad, Anne Largeot, Natalia Moncaut, et al.. (2024). The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency. Journal of Hematology & Oncology. 17(1). 91–91. 1 indexed citations
5.
Durand, Amandine, Daniela Lakomy, Laurent Martin, et al.. (2023). High IL1-RA Plasma Levels at Baseline Allow to Identify Hodgkin Lymphoma Patients with High Risk of Treatment Failure. Blood. 142(Supplement 1). 4389–4389.
6.
Aucagne, Romain, Cyril Fournier, Fabien Guidez, et al.. (2022). Repeat Element Activation-Driven Inflammation: Role of NFκB and Implications in Normal Development and Cancer?. Biomedicines. 10(12). 3101–3101. 7 indexed citations
7.
Aucagne, Romain, Caroline Truntzer, Cyril Fournier, et al.. (2022). Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers. 15(1). 158–158. 8 indexed citations
8.
Guidez, Fabien, et al.. (2022). Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies. Cancers. 14(21). 5443–5443. 18 indexed citations
9.
Uzan, Benjamin, Romain Aucagne, François Hermetet, et al.. (2019). T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7. Oncogene. 38(48). 7357–7365. 12 indexed citations
10.
Aucagne, Romain, Simon Girard, Nadine Mayotte, et al.. (2017). UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis. The FASEB Journal. 31(11). 5012–5018. 12 indexed citations
11.
Chrétien, Marie‐Lorraine, C. Legouge, Arlette Hammann, et al.. (2016). Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice. Experimental Hematology. 44(8). 727–739.e6. 14 indexed citations
12.
Bordeleau, Marie-Ève, Romain Aucagne, Jalila Chagraoui, et al.. (2014). UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity. Blood. 124(15). 2362–2369. 28 indexed citations
13.
Largeot, Anne, Jérôme Paggetti, Julien Broséus, et al.. (2013). Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 3054–3063. 5 indexed citations
14.
Lagrange, Brice, Nathalie Droin, Romain Aucagne, et al.. (2013). A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(8). 1936–1946. 40 indexed citations
15.
Bastié, Jean, Romain Aucagne, Nathalie Droin, Éric Solary, & Laurent Delva. (2012). Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations. Cellular and Molecular Life Sciences. 69(17). 2853–2861. 4 indexed citations
16.
Aucagne, Romain, Nathalie Droin, Jérôme Paggetti, et al.. (2011). Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. Journal of Clinical Investigation. 121(6). 2361–2370. 89 indexed citations
17.
Aucagne, Romain, Nathalie Droin, Éric Solary, Jean Bastié, & Laurent Delva. (2011). TIF1γ : un gène suppresseur de tumeur dans la leucémie myélomonocytaire chronique. médecine/sciences. 27(8-9). 696–698. 4 indexed citations
18.
Paggetti, Jérôme, Anne Largeot, Romain Aucagne, et al.. (2010). Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells. Oncogene. 29(36). 5019–5031. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026